Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis

Carsten Schwarz Patrick Vandeputte 1 Amandine Rougeron 2 Sandrine Giraud Thomas Dugé de Bernonville Ludovic Duvaux 3 Amandine Gastebois 4 Ana Alastruey-Izquierdo Maria Teresa Martin-Gomez Estrella Martin Mazuelos Amparo Sole Josep Cano 5 Javier Peman Guillermo Quindos Francoise Botterel 6, 7 Marie-Elisabeth Bougnoux 8 Sharon Chen Laurence Delhaes 9, 10 Loic Favennec 11 Stephane Ranque 12 Ludwig Sedlacek Joerg Steinmann Jose Vazquez 13 Craig Williams Wieland Meyer 14, 15 Solene Le Gal 16, 17 Gilles Nevez 16, 1 Maxime Fleury 1 Nicolas Papon 18 Francoise Symoens 19 Jean-Philippe Bouchara 1
Abstract : Cystic fibrosis (CF) is the major genetic inherited disease in Caucasian populations. The respiratory tract of CF patients displays a sticky viscous mucus, which allows for the entrapment of airborne bacteria and fungal spores and provides a suitable environment for growth of microorganisms, including numerous yeast and filamentous fungal species. As a consequence, respiratory infections are the major cause of morbidity and mortality in this clinical context. Although bacteria remain the most common agents of these infections, fungal respiratory infections have emerged as an important cause of disease. Therefore, the International Society for Human and Animal Mycology (ISHAM) has launched a working group on Fungal respiratory infections in Cystic Fibrosis (Fri-CF) in October 2006, which was subsequently approved by the European Confederation of Medical Mycology (ECMM). Meetings of this working group, comprising both clinicians and mycologists involved in the follow-up of CF patients, as well as basic scientists interested in the fungal species involved, provided the opportunity to initiate collaborative works aimed to improve our knowledge on these infections to assist clinicians in patient management. The current review highlights the outcomes of some of these collaborative works in clinical surveillance, pathogenesis and treatment, giving special emphasis to standardization of culture procedures, improvement of species identification methods including the development of nonculture-based diagnostic methods, microbiome studies and identification of new biological markers, and the description of genotyping studies aiming to differentiate transient carriage and chronic colonization of the airways. The review also reports on the breakthrough in sequencing the genomes of the main Scedosporium species as basis for a better understanding of the pathogenic mechanisms of these fungi, and discusses treatment options of infections caused by multidrug resistant microorganisms, such as Scedosporium and Lomentospora species and members of the Rasamsonia argillacea species complex.
Type de document :
Article dans une revue
Medical Mycology, Oxford University Press, 2018, 56 (suppl_1), pp.S42-S59. 〈10.1093/mmy/myx106〉
Liste complète des métadonnées

https://hal.archives-ouvertes.fr/hal-01789211
Contributeur : Isabelle Combe <>
Soumis le : jeudi 15 novembre 2018 - 15:53:21
Dernière modification le : samedi 1 décembre 2018 - 01:16:51

Fichier

myx106.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Licence


Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale 4.0 International License

Identifiants

Citation

Carsten Schwarz, Patrick Vandeputte, Amandine Rougeron, Sandrine Giraud, Thomas Dugé de Bernonville, et al.. Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis. Medical Mycology, Oxford University Press, 2018, 56 (suppl_1), pp.S42-S59. 〈10.1093/mmy/myx106〉. 〈hal-01789211〉

Partager

Métriques

Consultations de la notice

104

Téléchargements de fichiers

1